JPWO2023073925A1 - - Google Patents
Info
- Publication number
- JPWO2023073925A1 JPWO2023073925A1 JP2023556031A JP2023556031A JPWO2023073925A1 JP WO2023073925 A1 JPWO2023073925 A1 JP WO2023073925A1 JP 2023556031 A JP2023556031 A JP 2023556031A JP 2023556031 A JP2023556031 A JP 2023556031A JP WO2023073925 A1 JPWO2023073925 A1 JP WO2023073925A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2021/040030 WO2023073925A1 (ja) | 2021-10-29 | 2021-10-29 | 眼科組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023073925A1 true JPWO2023073925A1 (https=) | 2023-05-04 |
Family
ID=86157647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556031A Pending JPWO2023073925A1 (https=) | 2021-10-29 | 2021-10-29 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250228887A1 (https=) |
| EP (1) | EP4393496A4 (https=) |
| JP (1) | JPWO2023073925A1 (https=) |
| WO (1) | WO2023073925A1 (https=) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004250592A (ja) * | 2003-02-20 | 2004-09-09 | Seikagaku Kogyo Co Ltd | 紫外線照射による低分子化グリコサミノグリカンの製造方法 |
| JP2006022087A (ja) * | 2004-06-08 | 2006-01-26 | Rohto Pharmaceut Co Ltd | 眼科用清涼組成物 |
| JP2006193521A (ja) * | 2004-12-17 | 2006-07-27 | Rohto Pharmaceut Co Ltd | 眼科用組成物 |
| JP2013525335A (ja) * | 2010-04-21 | 2013-06-20 | オルス、ファルマ | 人工涙エマルション |
| WO2014196412A1 (ja) * | 2013-06-06 | 2014-12-11 | 千寿製薬株式会社 | 両性イオン性ソフトコンタクトレンズ用眼科用組成物 |
| JP2019182825A (ja) * | 2018-03-30 | 2019-10-24 | ロート製薬株式会社 | 眼科組成物 |
| WO2019216381A1 (ja) * | 2018-05-09 | 2019-11-14 | ロート製薬株式会社 | 眼科組成物 |
| JP2019199468A (ja) * | 2018-05-09 | 2019-11-21 | ロート製薬株式会社 | 水性眼科組成物 |
| JP2019199469A (ja) * | 2018-05-09 | 2019-11-21 | ロート製薬株式会社 | 水性眼科組成物 |
| JP2021075531A (ja) * | 2019-11-07 | 2021-05-20 | ロート製薬株式会社 | 眼科組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102119932A (zh) | 2009-12-25 | 2011-07-13 | 日本乐敦制药株式会社 | 硅酮水凝胶隐形眼镜用眼科组合物 |
| JPWO2021220712A1 (https=) * | 2020-04-30 | 2021-11-04 |
-
2021
- 2021-10-29 EP EP21962467.3A patent/EP4393496A4/en active Pending
- 2021-10-29 JP JP2023556031A patent/JPWO2023073925A1/ja active Pending
- 2021-10-29 US US18/703,041 patent/US20250228887A1/en active Pending
- 2021-10-29 WO PCT/JP2021/040030 patent/WO2023073925A1/ja not_active Ceased
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004250592A (ja) * | 2003-02-20 | 2004-09-09 | Seikagaku Kogyo Co Ltd | 紫外線照射による低分子化グリコサミノグリカンの製造方法 |
| JP2006022087A (ja) * | 2004-06-08 | 2006-01-26 | Rohto Pharmaceut Co Ltd | 眼科用清涼組成物 |
| JP2006193521A (ja) * | 2004-12-17 | 2006-07-27 | Rohto Pharmaceut Co Ltd | 眼科用組成物 |
| JP2013525335A (ja) * | 2010-04-21 | 2013-06-20 | オルス、ファルマ | 人工涙エマルション |
| WO2014196412A1 (ja) * | 2013-06-06 | 2014-12-11 | 千寿製薬株式会社 | 両性イオン性ソフトコンタクトレンズ用眼科用組成物 |
| JP2019182825A (ja) * | 2018-03-30 | 2019-10-24 | ロート製薬株式会社 | 眼科組成物 |
| WO2019216381A1 (ja) * | 2018-05-09 | 2019-11-14 | ロート製薬株式会社 | 眼科組成物 |
| JP2019199468A (ja) * | 2018-05-09 | 2019-11-21 | ロート製薬株式会社 | 水性眼科組成物 |
| JP2019199469A (ja) * | 2018-05-09 | 2019-11-21 | ロート製薬株式会社 | 水性眼科組成物 |
| JP2021075531A (ja) * | 2019-11-07 | 2021-05-20 | ロート製薬株式会社 | 眼科組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4393496A4 (en) | 2025-06-25 |
| EP4393496A1 (en) | 2024-07-03 |
| WO2023073925A1 (ja) | 2023-05-04 |
| US20250228887A1 (en) | 2025-07-17 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240814 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250930 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251128 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20260224 |